benign prostatic hyperplasia
Urology · 2008–2010
6decisions
3medicines
0carried consumer input
0individual submissions
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| dutasteride with tamsulosin hydrochloride Treatment of moderate to severe lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) where treatment has been initiated by a urologist. | Nov 2010 | Recommended with restriction | no section in document |
| tamsulosin hydrochloride Lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) | Nov 2010 | Recommended with restriction | unclear |
| dutasteride treatment of benign prostatic hyperplasia (BPH) in men over 50 years who meet certain criteria | Jul 2009 | Not recommended | no section in document |
| dutasteride Treatment, in combination with an alpha-antagonist, of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) where treatment is initiated by a… | Nov 2009 | Recommended with restriction | no section in document |
| tamsulosin hydrochloride Relief of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). | Mar 2008 | Not recommended | no section in document |
| tamsulosin hydrochloride Treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). | Nov 2008 | Recommended | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.